Superworth

Lexaria Bioscience EPS LEXX

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to May 31, 2026
−$5.25
Latest quarter, Q3 FY26
−$1.20
Fiscal year 2025
−$9.90

Lexaria Bioscience's earnings per share was −$5.25 over the twelve months to May 31, 2026.

In its latest quarter, Q3 FY26, it was −$1.20.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$9.90n/a
FY2024−$6.90n/a
FY2023−$15.60n/a
FY2022−$18.90n/a
FY2021−$13.05n/a
FY2020−$22.35n/a
FY2019−$18.00n/a
FY2018−$45.00n/a
FY2017−$18.00n/a
FY2016−$18.00n/a
FY2015−$18.00n/a
FY2014n/an/a
FY2014n/an/a
FY2011−$18.00n/a
FY2010n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q3 FY26−$1.20n/a−$5.25
Q2 FY26−$0.90n/a−$7.20
Q1 FY26−$1.05n/a−$8.55
Q4 FY25−$2.10n/a−$9.90
Q3 FY25−$3.15n/a−$9.90
Q2 FY25−$2.25n/a−$8.70
Q1 FY25−$2.40n/a−$7.35
Q4 FY24−$2.10n/a−$6.90
Q3 FY24−$1.95n/a−$7.05
Q2 FY24−$0.90n/a−$10.65
Q1 FY24−$1.95n/a−$13.05
Q4 FY23−$2.25n/a−$15.60

Against its peers

Companies in Healthcare nearest Lexaria Bioscience's size, closest first, today.

CompanyEPS, 12 monthsGrowth
LEXXLexaria Bioscience−$5.25
OXBROXBRIDGE RE HOLDINGS$0.02
EDUCEducational Development$0.19
GTIMGood Times Restaurants$0.21+75% a year
MDRRMedalist Diversified$3.84
BCGBinah Capital$0.16
VIPVulcan Infrastructure & Power$0.07
MXCMexco Energy$0.75−5% a year
CKXCKX Lands$1.42+647% a year
MSGMMotorsport Games$0.43+187% a year
ATCHAtlasClear$0.01
Peer median$0.20

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Lexaria Bioscience

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.